Stem Cells
-
A Stanford Medicine-led study found that residual liver cancer cells interact with neighboring macrophages to prompt the disease to reappear.
-
Lymphoma therapy shows promise
In an early Stanford Medicine study, CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response.
-
Chuck Chan dies at 48
The Stanford Medicine researcher was known for his groundbreaking work and his generous spirit as a mentor and colleague.
-
Two elected to National Academy of Medicine
Bonnie Maldonado and Kristy Red-Horse join distinguished society of physicians.
-
Stem cell therapy with Alzheimer’s
In a Stanford Medicine study, scientists transplanted stem cells into mice and found reduction of brain abnormalities typical of Alzheimer’s disease.
-
Antibody treatment rejuvenates stem cells
Old muscle stem cells express high levels of the cancer-associated molecule CD47. Blocking a pathway mediated by CD47 restored strength to old mice in a Stanford Medicine study.
-
Step toward growing organs
Researchers have shown initial viability of an embryo that contains both chimpanzee and macaque cells in a preliminary study that explores the feasibility of primate organ genesis.
-
Immunosuppression-free kidney transplant
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.
-
Ketogenic diet helps cells survive stress
Muscle stem cells enter a deep resting state during fasting or when fed a high-fat ketogenic diet, a Stanford-led study finds. This promotes stem cell resilience but slows injury repair.
-
Electric current aids stroke recovery
Stanford scientists have developed a device that delivers and electrically stimulates stem cells to promote stroke healing.
-
$12 million for stem cell trial
Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.
-
$31 million for stem cell clinical trials
The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.
- Addiction
- Aging & Geriatrics
- Anesthesiology & Pain Management
- Animal Research
- Artificial Intelligence (AI)
- Autoimmune Conditions
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Diseases
- Innovation & Technology
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health